Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Replagal

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: Fabry disease is a rare X-linked lysosomal storage disease caused by defective activity of the lysosomal enzyme… Expand
Review
2014
Review
2014
Enzyme replacement therapies substitute particular enzymes in individuals who have deficient or absent levels of enzymatic… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2012
2012
Agalsidasa; Malaltia de Fabry; Revisio sistematica; Agalsidase; Fabry's disease; Clinical trial; Enfermedad de Fabry; Revision… Expand
2010
2010
Eur J Clin Invest 2010; 40 (12): 1104–1112 
2007
2007
  • G. Pastores
  • Biologics : targets & therapy
  • 2007
  • Corpus ID: 17351645
Anderson-Fabry disease (AFD) is an X-linked storage disorder caused by a deficiency of the lysosomal hydrolase a-galactosidase A… Expand
Highly Cited
2004
Highly Cited
2004
Summary: Fabry disease is an X-linked glycosphingolipid storage disorder caused by a deficiency of α-galactosidase A. Affected… Expand
2003
2003
Enzyme therapy has proven safe and effective in preventing and reversing many manifestations in patients with Gaucher disease. On… Expand
2003
2003
Aim: To study the prevalence of peripheral vestibular deficit in male and female patients with Fabry disease and to assess the… Expand
2003
2003
Here we report on a 15-year-old patient with Fabry disease undergoing enzyme replacement therapy showing that this therapy is a… Expand
  • figure 1